These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20415236)

  • 21. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
    De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
    Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent intravenous pulse cyclophosphamide treatment in systemic lupus erythematosus.
    Malaviya AN; Singh RR; Sindhwani R; Singh YN; Ahujà RK; Bhuyan UN; Khare SD; Kumar A; Malaviya R; Negi PC
    Indian J Med Res; 1992 Apr; 96():101-8. PubMed ID: 1428048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of patients with biopsy-proven lupus nephritis in NUH.
    Gan HC; Hyoon K; Fong KY
    Singapore Med J; 2002 Dec; 43(12):614-6. PubMed ID: 12693764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tubulo-interstitial nephritis (TIN) with no glomerular lesions, distal renal tubular acidosis and asteatosis cutis in a patient with systemic lupus erythematosus (SLE): a case report].
    Ogura N; Baba Y; Sakai I; Taneichi K; Shibaki H
    Ryumachi; 1992 Oct; 32(5):508-14; discussion 512-3. PubMed ID: 1440088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of methylprednisolone pulse therapy in patients with lupus nephritis assessed by WHO morphologic classification].
    Makino H; Yamasaki Y; Hayashi Y; Haramoto T; Shikata K; Kumagai I; Taniai K; Takahashi K; Ota Z
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):791-9. PubMed ID: 2273595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.
    Ishizaki J; Saito K; Nawata M; Mizuno Y; Tokunaga M; Sawamukai N; Tamura M; Hirata S; Yamaoka K; Hasegawa H; Tanaka Y
    Rheumatology (Oxford); 2015 Mar; 54(3):405-12. PubMed ID: 25183834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse.
    Yumura W; Suganuma S; Nitta K; Sano Y; Uchida K; Nihei H
    Clin Exp Nephrol; 2004 Dec; 8(4):363-8. PubMed ID: 15619038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lupus nephritis in children].
    Zwolińska D; Kiliś-Pstrusińska K; Wikiera I; Medyńska A
    Pol Merkur Lekarski; 2000 Jul; 8(49):454-6. PubMed ID: 11070712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methylprednisolone pulse therapy in the early phases of lupus nephritis].
    Mitić I; Fele D; Lenert P; Curić S; Vodopivec S; Bozić D; Sakac V; Djisalov M; Ilić T; Sebić L; Djurdjević-Mirković T; Tepavcević P
    Srp Arh Celok Lek; 1996; 124 Suppl 1():67-9. PubMed ID: 9102936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lupus nephritis in Senegal: study of 42 cases].
    Dia D; Ka EF; Cissé M; Pouye A; Niang NM; Kane A; Dieng MT; Niang A; Ka MM; Diouf B; Ndiaye B; Moreira-Diop T
    Dakar Med; 2007; 52(1):23-6. PubMed ID: 19102087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of mixed connective tissue disease with lupus-like manifestations of the central nervous system, successfully treated with cyclophosphamide combined with prednisolone].
    Kuroki M; Okayama A; Kuwata G; Okamoto M; Tanaka G; Iga M; Kai Y; Matsuyama M; Murai K; Tsubouchi H
    Ryumachi; 2000 Jun; 40(3):627-32. PubMed ID: 10920688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
    Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
    Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus].
    Anić B; Crkvencić N; Mayer M; Bosnić D; Sentić M; Markeljević J; Cikes N
    Lijec Vjesn; 1999; 121(9-10):283-8. PubMed ID: 19658369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
    Gunnarsson I; Sundelin B; Heimbürger M; Forslid J; van Vollenhoven R; Lundberg I; Jacobson SH
    J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Massive uncomplicated vascular immune complex deposits in the kidney of a patient with systemic lupus erythematosus.
    Takazoe K; Shimada T; Nakano H; Kawamura T; Utsunomiya Y; Kanai T; Kitajima T; Yamaguchi Y; Joh K; Mitarai T; Sakai O
    Clin Nephrol; 1997 Sep; 48(3):195-8. PubMed ID: 9342493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.